人类中血栓的细胞和酶特征是依赖血管床的血管床
Matthew T Bender1, Anu Aggarwal2, Matthew Godwin2
1Department of Neurological Surgery, University of Rochester, Rochester, NY.
Blood vessels, thrombosis & hemostasis
|August 6, 2025
概括
了解血栓的组成是血管重塑的关键. 静脉血栓显示较高的矩阵金属蛋白酶-9活性,这表明早期干预可以防止不可逆转的变化.
科学领域:
- 心血管研究研究心血管研究
- 血栓形成和血液静止.
- 分子生物学分子生物学
背景情况:
- 血栓形成后血管重塑的机制尚不清楚.
- 静脉血栓塞栓症 (VTE) 的管理不一致.
- 急性动脉血栓,就像脑血管事故 (CVA),需要紧急干预.
研究的目的:
- 为了研究分子特征和thrombi.com的细胞含量.
- 为了获得有关血管改造过程的见解.
- 为了比较动脉和静脉血栓的特征.
主要方法:
- 用导管导向的血栓切除术 (CDT) 对25名患者 (13名CVA,8名PE,4名DVT) 进行.
- 从瘤中提取的蛋白质和RNA用于分析.
- 技术包括免疫阻塞,RNA测序和基因表达量化.
主要成果:
- 静脉血栓的蛋白质,白细胞 (单细胞) 和红细胞含量高于动脉血栓.
- 在这两种类型的血小板含量是相似的.
- 在两者中都存在矩阵金属蛋白酶 (MMP) 家族酶;在静脉血栓中,MMP9活性显著高于静脉血栓 (P=.005).
结论:
- 动脉和静脉血栓表现出不同的表型,具有影响血管改造的活性酶.
- 静脉血栓中的酶活性与血栓年龄相关.
- 早期的CDT可能对静脉循环至关重要,以防止不可逆转的血管重塑.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
909
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
909
01:30Venous Thrombosis I: Introduction
41
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
41
01:16Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22